Annexin A1 as a potential prognostic biomarker for COVID-19 disease: Case-control study.

Omer CanacikRamazan SabirliEmel AltintasEmre KarsliDenizhan KarisBuse KaymazGizem Tukenmez SabirliÖzgür KurtAylin Köseler

Published in: International journal of clinical practice (2021)

AnxA1 levels may be a beneficial biomarker in the diagnosis of COVID-19 pneumonia and in predicting the need for ICU treatment in patients with COVID-19 pneumonia at the time of admission to the emergency department.

Keyphrases

emergency department
coronavirus disease
sars cov
intensive care unit
respiratory failure
community acquired pneumonia
mechanical ventilation
human health
replacement therapy
adverse drug
smoking cessation